Fulfilling a commitment to diversity and inclusion in the Phase 3 COVE Study of the Moderna COVID-19 Vaccine, Moderna enlisted Patientory among other digital health companies for patient recruitment.

Patientory is super excited to contribute to Moderna’s Phase 3 trial enrollment as a trusted partner with Trialscope.

If you are interested in participating in the Moderna clinical trial, please register here.

Read more about the official press release here.

About TrialScope 

TrialScope gives your clinical trial data superpowers™. The TrialScope Transparency Cloud™ makes centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 16 of the top 20 clinical trial sponsors in the world, who rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit TrialScope.com.

About Patientory:

Patientory empowers healthcare systems, providers, and consumers with a single, secure application for sharing healthcare data, providing unprecedented insight into each patient’s health and resulting in better, healthier outcomes.  Patientory’s applications provide increased insight into an individual’s health management and empowers people to make better decisions, coordinate between care providers, and receive better care overall.